Tower Research Capital (TRC)’s Genetron Holdings Limited ADS GTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-43
Closed -$173 6194
2024
Q1
$173 Sell
43
-187
-81% -$718 ﹤0.01% 5608
2023
Q4
$844 Buy
230
+219
+1,991% +$764 ﹤0.01% 5487
2023
Q3
$27 Hold
11
﹤0.01% 5821
2023
Q2
$30 Hold
11
﹤0.01% 5903
2023
Q1
$0 Hold
11
﹤0.01% 6546
2022
Q4
$0 Hold
11
﹤0.01% 6623
2022
Q3
$0 Sell
11
-68
-86% -$229 ﹤0.01% 6716
2022
Q2
$0 Sell
79
-1,793
-96% -$9.2K ﹤0.01% 6760
2022
Q1
$12K Buy
1,872
+1,461
+355% +$16K ﹤0.01% 4119
2021
Q4
$8K Sell
411
-789
-66% -$26.2K ﹤0.01% 4848
2021
Q3
$50K Buy
1,200
+1,040
+650% +$47.9K ﹤0.01% 2973
2021
Q2
$10K Buy
+160
New +$9.88K ﹤0.01% 4411
2020
Q3
Sell
-133
Closed -$5K 5192
2020
Q2
$5K Buy
+133
New +$5.39K ﹤0.01% 4308

Tower Research Capital (TRC)'s GTH Position: Q2 2024 in Review

Tower Research Capital (TRC) sold out of Genetron Holdings Limited ADS (GTH) in Q2 2024, closing a stake of 43 shares — an estimated $173 sold.

Tower Research Capital (TRC) first reported a position in GTH in Q2 2020 and held it in 13 quarters. The position peaked at $50K in Q3 2021. 0 funds tracked by Wall St. Rank hold GTH as of Q2 2024.

  • Tower Research Capital (TRC) reported no remaining Genetron Holdings Limited ADS position as of Q2 2024 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 43 Genetron Holdings Limited ADS shares in Q2 2024, an estimated $173.
  • Tower Research Capital (TRC) first reported a position in Genetron Holdings Limited ADS in Q2 2020 and held it in 13 quarters.
  • Tower Research Capital (TRC)'s Genetron Holdings Limited ADS position peaked at $50K in Q3 2021.
  • 0 funds tracked by Wall St. Rank held Genetron Holdings Limited ADS as of Q2 2024.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2024, filed 13 Aug 2024.